MTOR and glioblastoma: One of the mechanisms used by GBM cells to resist mTOR inhibitors involves an increase in IRES-dependent translation and thus an upregulation of proteins coded by IRES-containing mRNAs such as c-myc and cyclin D1, two well-known proto-oncogenes [28,124,125].